Abstract:Abstract Background Liver cancer is among the most common malignancy worldwide. Hepatocellular carcinoma (HCC), the principal histological subtype of liver cancer, is globally the third most common cause of cancer-related mortality. The high rates of recurrence and metastasis contribute to the poor prognosis of HCC patients. In recent years, increasing evidence has shown that microRNAs (miRNAs) are involved in the tumorigenesis, progression, and prognosis of HCC. Methods To screen for key candidate miRNAs in HCC, three microarray datasets were downloaded from Gene Expression Omnibus (GEO). The sole common differentially expressed miRNA (DEmiR) observed in the above three datasets using a Venn diagram was microRNA-211-5p (miR-211-5p). The expression of miR-211-5p from HCC tissues was measured in several HCC cell lines. Additionally, using Kaplan–Meier plots, the potential prognostic value of miR-211-5p in HCC was analyzed. Cell counting kit-8 (CCK-8) and transwell assays examined the ability of miR-211-5p to induce cell proliferation, migration, and invasion in HCC cultures. The interaction of miR-211-5p and Acyl-CoA Synthetase Long Chain Family Member 4 (ACSL4) was assessed both theoretically and using a luciferase reporter assay. Finally, the ability of miR-211-5p to modulate tumorigenesis in HCC in vivo was assessed after establishing a xenograft model. Results qRT-PCR demonstrated that the relative expression of miR-211-5p was considerably down-regulated in HCC tissues and cell lines compared with normal tissue. Kaplan–Meier plots indicated that HCC patients with decreased expression of miR-211-5p had poor overall survival. Upregulation of miR-211-5p in vitro consistently suppressed cell proliferation, migration, and invasion. In contrast, enhanced expression of ACSL4 promoted a malignant phenotype in HCC cells. Importantly, we discovered that ACSL4 was a direct downstream target of miR-211-5p in HCC, and that miR-211-5p suppressed the malignant phenotype by inhibition of ACSL4 expression. Furthermore, miR-211-5p overexpression impaired tumorigenesis and growth of HCC in vivo. Conclusions Targeting miR-211-5p and the downstream gene ACSL4 will possibly provide novel insight and represents a promising approach to future therapy of HCC patients.

Targeting the Microrna-21/Ap1 Axis by 5-Fluorouracil and Pirarubicin in Human Hepatocellular Carcinoma

Anti–miR-21 Suppresses Hepatocellular Carcinoma Growth Via Broad Transcriptional Network Deregulation

Tumor-triggered Personalized Microrna Cocktail Therapy for Hepatocellular Carcinoma

Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma

Systemic Delivery of Microrna-101 Potently Inhibits Hepatocellular Carcinoma in Vivo by Repressing Multiple Targets

Investigation of the clinical significance and molecular mechanism of miR-21-5p in hepatocellular carcinoma: A systematic review based on 24 studies and bioinformatics investigation.

MicroRNA-181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG

Significance of Serum Microrna-21 in Diagnosis of Hepatocellular Carcinoma (HCC): Clinical Analyses of Patients and an HCC Rat Model.

Screening and Molecular Mechanism Research on Bile Micrornas Associated with Chemotherapy Efficacy in Perihilar Cholangiocarcinoma

MicroRNA‑133a and microRNA‑326 co‑contribute to hepatocellular carcinoma 5‑fluorouracil and cisplatin sensitivity by directly targeting B‑cell lymphoma‑extra large

MicroRNA-21 Promotes Hepatocellular Carcinoma HepG2 Cell Proliferation Through Repression of Mitogen-Activated Protein Kinase-Kinase 3

Functional Analysis of Micrornas in Human Hepatocellular Cancer Stem Cells

MicroRNA in HCC: Biomarkers and Therapeutic Targets

Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties.

Decrease Expression of Microrna-20a Promotes Cancer Cell Proliferation and Predicts Poor Survival of Hepatocellular Carcinoma

MicroRNA-302a enhances 5-fluorouracil sensitivity in HepG2 cells by increasing AKT/ULK1-dependent autophagy-mediated apoptosis

Mir-21 Promotes Intrahepatic Cholangiocarcinoma Proliferation and Growth in Vitro and in Vivo by Targeting Ptpn14 and Pten

miR-21: A therapeutic target for delaying severe liver disease and hepatocellular carcinoma in high-fat-diet-fed mice

Micro-RNA-21 Rs1292037 A>G Polymorphism Can Predict Hepatocellular Carcinoma Prognosis (HCC), and Plays a Key Role in Cell Proliferation and Ischemia-Reperfusion Injury (IRI) in HCC Cell Model of IRI

The Role and Clinical Implications of Micrornas in Hepatocellular Carcinoma

Mir-21 Promotes Migration and Invasion by the Mir-21-Pdcd4-Ap-1 Feedback Loop in Human Hepatocellular Carcinoma